nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—CYP2E1—Dacarbazine—muscle cancer	0.247	0.362	CbGbCtD
Aminophylline—CYP1A2—Dacarbazine—muscle cancer	0.143	0.209	CbGbCtD
Aminophylline—CYP2E1—Etoposide—muscle cancer	0.121	0.177	CbGbCtD
Aminophylline—CYP1A2—Etoposide—muscle cancer	0.0699	0.102	CbGbCtD
Aminophylline—CYP3A4—Vincristine—muscle cancer	0.04	0.0586	CbGbCtD
Aminophylline—CYP3A4—Etoposide—muscle cancer	0.0366	0.0537	CbGbCtD
Aminophylline—CYP3A4—Doxorubicin—muscle cancer	0.025	0.0366	CbGbCtD
Aminophylline—HDAC2—Teniposide—Etoposide—muscle cancer	0.00989	1	CbGdCrCtD
Aminophylline—ADORA2B—C-MYB transcription factor network—MYF6—muscle cancer	0.00612	0.0773	CbGpPWpGaD
Aminophylline—Skin necrosis—Etoposide—muscle cancer	0.00556	0.0374	CcSEcCtD
Aminophylline—ADORA2B—smooth muscle tissue—muscle cancer	0.00487	0.0611	CbGeAlD
Aminophylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MYF5—muscle cancer	0.00449	0.0568	CbGpPWpGaD
Aminophylline—Bronchial hyperreactivity—Methotrexate—muscle cancer	0.00446	0.03	CcSEcCtD
Aminophylline—HDAC2—embryo—muscle cancer	0.0044	0.0551	CbGeAlD
Aminophylline—Inappropriate antidiuretic hormone secretion—Vincristine—muscle cancer	0.00413	0.0277	CcSEcCtD
Aminophylline—Chronic obstructive pulmonary disease—Methotrexate—muscle cancer	0.00408	0.0274	CcSEcCtD
Aminophylline—PDE3A—smooth muscle tissue—muscle cancer	0.00359	0.045	CbGeAlD
Aminophylline—Abdominal cramps—Vincristine—muscle cancer	0.00356	0.0239	CcSEcCtD
Aminophylline—HDAC2—smooth muscle tissue—muscle cancer	0.00346	0.0433	CbGeAlD
Aminophylline—ADORA2B—vagina—muscle cancer	0.0034	0.0426	CbGeAlD
Aminophylline—ADORA1—renal system—muscle cancer	0.00337	0.0422	CbGeAlD
Aminophylline—Skin necrosis—Methotrexate—muscle cancer	0.00333	0.0224	CcSEcCtD
Aminophylline—HDAC2—renal system—muscle cancer	0.00333	0.0417	CbGeAlD
Aminophylline—HDAC2—Regulation of nuclear SMAD2/3 signaling—TFE3—muscle cancer	0.00322	0.0406	CbGpPWpGaD
Aminophylline—HDAC2—Neural Crest Differentiation—PAX7—muscle cancer	0.00317	0.0401	CbGpPWpGaD
Aminophylline—ADORA2B—head—muscle cancer	0.00314	0.0393	CbGeAlD
Aminophylline—PDE3A—cardiac atrium—muscle cancer	0.0031	0.0388	CbGeAlD
Aminophylline—Extravasation—Dactinomycin—muscle cancer	0.00308	0.0207	CcSEcCtD
Aminophylline—ADORA2B—testis—muscle cancer	0.00303	0.038	CbGeAlD
Aminophylline—ADORA1—cardiac atrium—muscle cancer	0.00302	0.0378	CbGeAlD
Aminophylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MYOG—muscle cancer	0.0029	0.0366	CbGpPWpGaD
Aminophylline—Skin necrosis—Doxorubicin—muscle cancer	0.00289	0.0194	CcSEcCtD
Aminophylline—Extravasation—Vincristine—muscle cancer	0.00275	0.0185	CcSEcCtD
Aminophylline—PDE4A—testis—muscle cancer	0.0027	0.0339	CbGeAlD
Aminophylline—PDE3A—tendon—muscle cancer	0.0027	0.0338	CbGeAlD
Aminophylline—HDAC2—Neural Crest Differentiation—PAX3—muscle cancer	0.0027	0.0341	CbGpPWpGaD
Aminophylline—ADORA1—tendon—muscle cancer	0.00263	0.033	CbGeAlD
Aminophylline—ADORA2A—head—muscle cancer	0.00261	0.0327	CbGeAlD
Aminophylline—HDAC2—tendon—muscle cancer	0.0026	0.0326	CbGeAlD
Aminophylline—Hyperuricaemia—Vincristine—muscle cancer	0.00259	0.0174	CcSEcCtD
Aminophylline—ADORA2A—testis—muscle cancer	0.00252	0.0316	CbGeAlD
Aminophylline—HDAC2—bone marrow—muscle cancer	0.00252	0.0315	CbGeAlD
Aminophylline—Sinus tachycardia—Doxorubicin—muscle cancer	0.0025	0.0168	CcSEcCtD
Aminophylline—Blood uric acid increased—Vincristine—muscle cancer	0.00244	0.0164	CcSEcCtD
Aminophylline—ADORA1—vagina—muscle cancer	0.00244	0.0306	CbGeAlD
Aminophylline—ADORA2B—C-MYB transcription factor network—CD34—muscle cancer	0.00244	0.0308	CbGpPWpGaD
Aminophylline—ADORA2B—C-MYB transcription factor network—MYOD1—muscle cancer	0.00244	0.0308	CbGpPWpGaD
Aminophylline—HDAC2—vagina—muscle cancer	0.00241	0.0302	CbGeAlD
Aminophylline—Phlebitis—Dactinomycin—muscle cancer	0.00226	0.0152	CcSEcCtD
Aminophylline—ADORA1—head—muscle cancer	0.00225	0.0283	CbGeAlD
Aminophylline—PDE3A—testis—muscle cancer	0.00224	0.028	CbGeAlD
Aminophylline—Extravasation—Etoposide—muscle cancer	0.00223	0.015	CcSEcCtD
Aminophylline—HDAC2—head—muscle cancer	0.00223	0.0279	CbGeAlD
Aminophylline—Coma—Vincristine—muscle cancer	0.00219	0.0147	CcSEcCtD
Aminophylline—ADORA1—testis—muscle cancer	0.00218	0.0273	CbGeAlD
Aminophylline—HDAC2—testis—muscle cancer	0.00215	0.027	CbGeAlD
Aminophylline—HDAC2—Hedgehog signaling events mediated by Gli proteins—PTCH1—muscle cancer	0.00213	0.0269	CbGpPWpGaD
Aminophylline—Hyperuricaemia—Etoposide—muscle cancer	0.0021	0.0141	CcSEcCtD
Aminophylline—Polyuria—Vincristine—muscle cancer	0.00198	0.0133	CcSEcCtD
Aminophylline—Blood uric acid increased—Etoposide—muscle cancer	0.00198	0.0133	CcSEcCtD
Aminophylline—HDAC2—Regulation of Telomerase—WT1—muscle cancer	0.00189	0.0239	CbGpPWpGaD
Aminophylline—Venous thrombosis—Doxorubicin—muscle cancer	0.00187	0.0125	CcSEcCtD
Aminophylline—Skin exfoliation—Etoposide—muscle cancer	0.00186	0.0125	CcSEcCtD
Aminophylline—HDAC2—Regulation of nuclear SMAD2/3 signaling—MYOD1—muscle cancer	0.00177	0.0224	CbGpPWpGaD
Aminophylline—Haematemesis—Methotrexate—muscle cancer	0.00168	0.0113	CcSEcCtD
Aminophylline—Urinary retention—Vincristine—muscle cancer	0.00166	0.0111	CcSEcCtD
Aminophylline—Phlebitis—Etoposide—muscle cancer	0.00164	0.011	CcSEcCtD
Aminophylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—muscle cancer	0.00164	0.0207	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIDINS220—muscle cancer	0.00157	0.0198	CbGpPWpGaD
Aminophylline—CYP1A2—renal system—muscle cancer	0.00153	0.0192	CbGeAlD
Aminophylline—HDAC2—Direct p53 effectors—PMS2—muscle cancer	0.00151	0.0191	CbGpPWpGaD
Aminophylline—Anaphylactoid reaction—Etoposide—muscle cancer	0.00146	0.00979	CcSEcCtD
Aminophylline—Hypercalcaemia—Doxorubicin—muscle cancer	0.00145	0.00975	CcSEcCtD
Aminophylline—Haematemesis—Doxorubicin—muscle cancer	0.00145	0.00975	CcSEcCtD
Aminophylline—HDAC2—Direct p53 effectors—TP73—muscle cancer	0.0014	0.0177	CbGpPWpGaD
Aminophylline—CYP2E1—renal system—muscle cancer	0.00138	0.0173	CbGeAlD
Aminophylline—Ventricular arrhythmia—Doxorubicin—muscle cancer	0.00136	0.00915	CcSEcCtD
Aminophylline—Albuminuria—Doxorubicin—muscle cancer	0.00135	0.00907	CcSEcCtD
Aminophylline—Extravasation—Methotrexate—muscle cancer	0.00133	0.00896	CcSEcCtD
Aminophylline—HDAC2—Signaling by NGF—KIDINS220—muscle cancer	0.0013	0.0164	CbGpPWpGaD
Aminophylline—Hyperuricaemia—Methotrexate—muscle cancer	0.00126	0.00843	CcSEcCtD
Aminophylline—Flushing—Dactinomycin—muscle cancer	0.00125	0.00841	CcSEcCtD
Aminophylline—HDAC2—Direct p53 effectors—TP63—muscle cancer	0.00121	0.0152	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—KIDINS220—muscle cancer	0.00121	0.0152	CbGpPWpGaD
Aminophylline—HDAC2—Regulation of nuclear SMAD2/3 signaling—FOXO4—muscle cancer	0.0012	0.0152	CbGpPWpGaD
Aminophylline—Alopecia—Dactinomycin—muscle cancer	0.00119	0.008	CcSEcCtD
Aminophylline—Blood uric acid increased—Methotrexate—muscle cancer	0.00119	0.00796	CcSEcCtD
Aminophylline—Extravasation—Doxorubicin—muscle cancer	0.00116	0.00776	CcSEcCtD
Aminophylline—Ventricular extrasystoles—Doxorubicin—muscle cancer	0.00112	0.0075	CcSEcCtD
Aminophylline—Skin exfoliation—Methotrexate—muscle cancer	0.00111	0.00747	CcSEcCtD
Aminophylline—CYP3A4—renal system—muscle cancer	0.00111	0.0139	CbGeAlD
Aminophylline—Hyperuricaemia—Doxorubicin—muscle cancer	0.00109	0.0073	CcSEcCtD
Aminophylline—CYP2E1—tendon—muscle cancer	0.00108	0.0135	CbGeAlD
Aminophylline—Alopecia—Vincristine—muscle cancer	0.00107	0.00715	CcSEcCtD
Aminophylline—Coma—Methotrexate—muscle cancer	0.00106	0.00715	CcSEcCtD
Aminophylline—Blood uric acid increased—Doxorubicin—muscle cancer	0.00103	0.0069	CcSEcCtD
Aminophylline—HDAC2—Cell Cycle—BUB1B—muscle cancer	0.001	0.0126	CbGpPWpGaD
Aminophylline—ADORA2A—GPCRs, Other—CNR1—muscle cancer	0.001	0.0126	CbGpPWpGaD
Aminophylline—Dermatitis contact—Doxorubicin—muscle cancer	0.000997	0.00669	CcSEcCtD
Aminophylline—Agitation—Vincristine—muscle cancer	0.000964	0.00647	CcSEcCtD
Aminophylline—Polyuria—Methotrexate—muscle cancer	0.000963	0.00646	CcSEcCtD
Aminophylline—Skin exfoliation—Doxorubicin—muscle cancer	0.000963	0.00646	CcSEcCtD
Aminophylline—Infection—Dactinomycin—muscle cancer	0.000952	0.00639	CcSEcCtD
Aminophylline—ADORA2B—C-MYB transcription factor network—KIT—muscle cancer	0.000932	0.0118	CbGpPWpGaD
Aminophylline—CYP2E1—head—muscle cancer	0.000922	0.0116	CbGeAlD
Aminophylline—Coma—Doxorubicin—muscle cancer	0.000921	0.00619	CcSEcCtD
Aminophylline—Anorexia—Dactinomycin—muscle cancer	0.000914	0.00613	CcSEcCtD
Aminophylline—Convulsion—Vincristine—muscle cancer	0.000909	0.0061	CcSEcCtD
Aminophylline—Flushing—Etoposide—muscle cancer	0.000906	0.00608	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000896	0.00602	CcSEcCtD
Aminophylline—CYP2E1—testis—muscle cancer	0.00089	0.0112	CbGeAlD
Aminophylline—HDAC2—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	0.000889	0.0112	CbGpPWpGaD
Aminophylline—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000873	0.00587	CcSEcCtD
Aminophylline—Alopecia—Etoposide—muscle cancer	0.000863	0.00579	CcSEcCtD
Aminophylline—Anaphylactic shock—Vincristine—muscle cancer	0.000856	0.00575	CcSEcCtD
Aminophylline—Infection—Vincristine—muscle cancer	0.000851	0.00571	CcSEcCtD
Aminophylline—Phlebitis—Doxorubicin—muscle cancer	0.00085	0.00571	CcSEcCtD
Aminophylline—Nervous system disorder—Vincristine—muscle cancer	0.00084	0.00564	CcSEcCtD
Aminophylline—Decreased appetite—Dactinomycin—muscle cancer	0.000833	0.00559	CcSEcCtD
Aminophylline—Anorexia—Vincristine—muscle cancer	0.000816	0.00548	CcSEcCtD
Aminophylline—Irritability—Methotrexate—muscle cancer	0.000807	0.00542	CcSEcCtD
Aminophylline—Hypotension—Vincristine—muscle cancer	0.0008	0.00537	CcSEcCtD
Aminophylline—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000784	0.00526	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000776	0.00521	CcSEcCtD
Aminophylline—Insomnia—Vincristine—muscle cancer	0.000774	0.0052	CcSEcCtD
Aminophylline—Body temperature increased—Dactinomycin—muscle cancer	0.000758	0.00509	CcSEcCtD
Aminophylline—Abdominal pain—Dactinomycin—muscle cancer	0.000758	0.00509	CcSEcCtD
Aminophylline—ADORA2B—C-MYB transcription factor network—CDKN2A—muscle cancer	0.000757	0.00956	CbGpPWpGaD
Aminophylline—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000756	0.00508	CcSEcCtD
Aminophylline—ADORA2A—HIF-2-alpha transcription factor network—VEGFA—muscle cancer	0.000755	0.00953	CbGpPWpGaD
Aminophylline—Decreased appetite—Vincristine—muscle cancer	0.000744	0.005	CcSEcCtD
Aminophylline—Convulsion—Etoposide—muscle cancer	0.000736	0.00494	CcSEcCtD
Aminophylline—ADORA2B—C-MYB transcription factor network—PTGS2—muscle cancer	0.000708	0.00894	CbGpPWpGaD
Aminophylline—Hypersensitivity—Dactinomycin—muscle cancer	0.000706	0.00474	CcSEcCtD
Aminophylline—Gastrointestinal pain—Vincristine—muscle cancer	0.0007	0.0047	CcSEcCtD
Aminophylline—Anaphylactic shock—Etoposide—muscle cancer	0.000694	0.00466	CcSEcCtD
Aminophylline—Infection—Etoposide—muscle cancer	0.000689	0.00463	CcSEcCtD
Aminophylline—Tachycardia—Etoposide—muscle cancer	0.000677	0.00455	CcSEcCtD
Aminophylline—Abdominal pain—Vincristine—muscle cancer	0.000677	0.00455	CcSEcCtD
Aminophylline—Body temperature increased—Vincristine—muscle cancer	0.000677	0.00455	CcSEcCtD
Aminophylline—Abdominal pain upper—Doxorubicin—muscle cancer	0.000669	0.00449	CcSEcCtD
Aminophylline—Hypokalaemia—Doxorubicin—muscle cancer	0.000666	0.00447	CcSEcCtD
Aminophylline—ADORA2B—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000663	0.00837	CbGpPWpGaD
Aminophylline—Anorexia—Etoposide—muscle cancer	0.000661	0.00444	CcSEcCtD
Aminophylline—Diarrhoea—Dactinomycin—muscle cancer	0.000656	0.0044	CcSEcCtD
Aminophylline—Hypotension—Etoposide—muscle cancer	0.000648	0.00435	CcSEcCtD
Aminophylline—Hypersensitivity—Vincristine—muscle cancer	0.000631	0.00424	CcSEcCtD
Aminophylline—Haematuria—Methotrexate—muscle cancer	0.000621	0.00417	CcSEcCtD
Aminophylline—Vomiting—Dactinomycin—muscle cancer	0.000609	0.00409	CcSEcCtD
Aminophylline—ADORA1—G alpha (i) signalling events—CNR1—muscle cancer	0.000607	0.00767	CbGpPWpGaD
Aminophylline—Rash—Dactinomycin—muscle cancer	0.000604	0.00406	CcSEcCtD
Aminophylline—Decreased appetite—Etoposide—muscle cancer	0.000603	0.00405	CcSEcCtD
Aminophylline—Diarrhoea—Vincristine—muscle cancer	0.000586	0.00393	CcSEcCtD
Aminophylline—PDE3A—Hemostasis—ANGPT2—muscle cancer	0.000574	0.00725	CbGpPWpGaD
Aminophylline—Hyperglycaemia—Doxorubicin—muscle cancer	0.000571	0.00383	CcSEcCtD
Aminophylline—Nausea—Dactinomycin—muscle cancer	0.000569	0.00382	CcSEcCtD
Aminophylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000568	0.00717	CbGpPWpGaD
Aminophylline—Gastrointestinal pain—Etoposide—muscle cancer	0.000567	0.00381	CcSEcCtD
Aminophylline—Dizziness—Vincristine—muscle cancer	0.000566	0.0038	CcSEcCtD
Aminophylline—ADORA1—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000563	0.00712	CbGpPWpGaD
Aminophylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—muscle cancer	0.000556	0.00702	CbGpPWpGaD
Aminophylline—Urticaria—Etoposide—muscle cancer	0.000551	0.0037	CcSEcCtD
Aminophylline—Abdominal pain—Etoposide—muscle cancer	0.000548	0.00368	CcSEcCtD
Aminophylline—Body temperature increased—Etoposide—muscle cancer	0.000548	0.00368	CcSEcCtD
Aminophylline—Vomiting—Vincristine—muscle cancer	0.000544	0.00366	CcSEcCtD
Aminophylline—Rash—Vincristine—muscle cancer	0.00054	0.00363	CcSEcCtD
Aminophylline—Dermatitis—Vincristine—muscle cancer	0.000539	0.00362	CcSEcCtD
Aminophylline—Haematuria—Doxorubicin—muscle cancer	0.000538	0.00361	CcSEcCtD
Aminophylline—Headache—Vincristine—muscle cancer	0.000536	0.0036	CcSEcCtD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—FOXO4—muscle cancer	0.000531	0.0067	CbGpPWpGaD
Aminophylline—HDAC2—Glucocorticoid receptor regulatory network—MDM2—muscle cancer	0.000529	0.00668	CbGpPWpGaD
Aminophylline—CYP1A2—Melatonin metabolism and effects—FOXO1—muscle cancer	0.000522	0.00659	CbGpPWpGaD
Aminophylline—Alopecia—Methotrexate—muscle cancer	0.000517	0.00347	CcSEcCtD
Aminophylline—ADORA2B—GPCR ligand binding—PTCH1—muscle cancer	0.000512	0.00647	CbGpPWpGaD
Aminophylline—Hypersensitivity—Etoposide—muscle cancer	0.000511	0.00343	CcSEcCtD
Aminophylline—Nausea—Vincristine—muscle cancer	0.000509	0.00342	CcSEcCtD
Aminophylline—Pruritus—Etoposide—muscle cancer	0.000491	0.0033	CcSEcCtD
Aminophylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000483	0.0061	CbGpPWpGaD
Aminophylline—Diarrhoea—Etoposide—muscle cancer	0.000475	0.00319	CcSEcCtD
Aminophylline—Flushing—Doxorubicin—muscle cancer	0.00047	0.00316	CcSEcCtD
Aminophylline—HDAC2—Hemostasis—ANGPT2—muscle cancer	0.000459	0.0058	CbGpPWpGaD
Aminophylline—Dizziness—Etoposide—muscle cancer	0.000459	0.00308	CcSEcCtD
Aminophylline—HDAC2—Cell Cycle—CDKN2A—muscle cancer	0.000458	0.00578	CbGpPWpGaD
Aminophylline—Arrhythmia—Doxorubicin—muscle cancer	0.000452	0.00304	CcSEcCtD
Aminophylline—Alopecia—Doxorubicin—muscle cancer	0.000447	0.003	CcSEcCtD
Aminophylline—HDAC2—Cell Cycle—MDM2—muscle cancer	0.000444	0.00561	CbGpPWpGaD
Aminophylline—Convulsion—Methotrexate—muscle cancer	0.000441	0.00296	CcSEcCtD
Aminophylline—Vomiting—Etoposide—muscle cancer	0.000441	0.00296	CcSEcCtD
Aminophylline—HDAC2—Signaling by NGF—FOXO4—muscle cancer	0.000439	0.00554	CbGpPWpGaD
Aminophylline—Rash—Etoposide—muscle cancer	0.000437	0.00294	CcSEcCtD
Aminophylline—Dermatitis—Etoposide—muscle cancer	0.000437	0.00293	CcSEcCtD
Aminophylline—ADORA1—GPCR ligand binding—PTCH1—muscle cancer	0.000435	0.0055	CbGpPWpGaD
Aminophylline—ADORA2A—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000435	0.00549	CbGpPWpGaD
Aminophylline—Headache—Etoposide—muscle cancer	0.000435	0.00292	CcSEcCtD
Aminophylline—Tension—Doxorubicin—muscle cancer	0.000433	0.0029	CcSEcCtD
Aminophylline—ADORA2B—GPCR ligand binding—CNR1—muscle cancer	0.000432	0.00546	CbGpPWpGaD
Aminophylline—Nervousness—Doxorubicin—muscle cancer	0.000428	0.00288	CcSEcCtD
Aminophylline—Anaphylactic shock—Methotrexate—muscle cancer	0.000415	0.00279	CcSEcCtD
Aminophylline—Infection—Methotrexate—muscle cancer	0.000413	0.00277	CcSEcCtD
Aminophylline—Nausea—Etoposide—muscle cancer	0.000412	0.00277	CcSEcCtD
Aminophylline—ADORA2A—Signaling by NGF—FOXO4—muscle cancer	0.000408	0.00515	CbGpPWpGaD
Aminophylline—Nervous system disorder—Methotrexate—muscle cancer	0.000407	0.00274	CcSEcCtD
Aminophylline—Agitation—Doxorubicin—muscle cancer	0.000405	0.00272	CcSEcCtD
Aminophylline—Anorexia—Methotrexate—muscle cancer	0.000396	0.00266	CcSEcCtD
Aminophylline—ADORA2B—Signaling Pathways—KIDINS220—muscle cancer	0.000394	0.00498	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—FOXO1—muscle cancer	0.000392	0.00495	CbGpPWpGaD
Aminophylline—Palpitations—Doxorubicin—muscle cancer	0.00039	0.00262	CcSEcCtD
Aminophylline—Hypotension—Methotrexate—muscle cancer	0.000388	0.00261	CcSEcCtD
Aminophylline—Convulsion—Doxorubicin—muscle cancer	0.000382	0.00256	CcSEcCtD
Aminophylline—Insomnia—Methotrexate—muscle cancer	0.000376	0.00252	CcSEcCtD
Aminophylline—Anxiety—Doxorubicin—muscle cancer	0.000374	0.00251	CcSEcCtD
Aminophylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000373	0.00471	CbGpPWpGaD
Aminophylline—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000372	0.0047	CbGpPWpGaD
Aminophylline—ADORA1—GPCR ligand binding—CNR1—muscle cancer	0.000368	0.00464	CbGpPWpGaD
Aminophylline—Dyspepsia—Methotrexate—muscle cancer	0.000366	0.00246	CcSEcCtD
Aminophylline—Decreased appetite—Methotrexate—muscle cancer	0.000361	0.00243	CcSEcCtD
Aminophylline—CYP2E1—Tryptophan metabolism—MDM2—muscle cancer	0.00036	0.00455	CbGpPWpGaD
Aminophylline—Anaphylactic shock—Doxorubicin—muscle cancer	0.00036	0.00242	CcSEcCtD
Aminophylline—PDE4A—Signaling Pathways—KIDINS220—muscle cancer	0.000358	0.00452	CbGpPWpGaD
Aminophylline—Infection—Doxorubicin—muscle cancer	0.000357	0.0024	CcSEcCtD
Aminophylline—Shock—Doxorubicin—muscle cancer	0.000354	0.00238	CcSEcCtD
Aminophylline—Nervous system disorder—Doxorubicin—muscle cancer	0.000353	0.00237	CcSEcCtD
Aminophylline—Tachycardia—Doxorubicin—muscle cancer	0.000351	0.00236	CcSEcCtD
Aminophylline—PDE3A—Signaling Pathways—KIDINS220—muscle cancer	0.000348	0.0044	CbGpPWpGaD
Aminophylline—HDAC2—Direct p53 effectors—MDM2—muscle cancer	0.000345	0.00435	CbGpPWpGaD
Aminophylline—Anorexia—Doxorubicin—muscle cancer	0.000343	0.0023	CcSEcCtD
Aminophylline—Gastrointestinal pain—Methotrexate—muscle cancer	0.00034	0.00228	CcSEcCtD
Aminophylline—ADORA2A—GPCR ligand binding—PTCH1—muscle cancer	0.000336	0.00425	CbGpPWpGaD
Aminophylline—Hypotension—Doxorubicin—muscle cancer	0.000336	0.00226	CcSEcCtD
Aminophylline—ADORA1—Signaling Pathways—KIDINS220—muscle cancer	0.000335	0.00424	CbGpPWpGaD
Aminophylline—Urticaria—Methotrexate—muscle cancer	0.00033	0.00222	CcSEcCtD
Aminophylline—Abdominal pain—Methotrexate—muscle cancer	0.000328	0.00221	CcSEcCtD
Aminophylline—Body temperature increased—Methotrexate—muscle cancer	0.000328	0.00221	CcSEcCtD
Aminophylline—Insomnia—Doxorubicin—muscle cancer	0.000325	0.00219	CcSEcCtD
Aminophylline—HDAC2—Signaling by NGF—FOXO1—muscle cancer	0.000324	0.00409	CbGpPWpGaD
Aminophylline—Dyspepsia—Doxorubicin—muscle cancer	0.000317	0.00213	CcSEcCtD
Aminophylline—Decreased appetite—Doxorubicin—muscle cancer	0.000313	0.0021	CcSEcCtD
Aminophylline—Hypersensitivity—Methotrexate—muscle cancer	0.000306	0.00206	CcSEcCtD
Aminophylline—HDAC2—Glucocorticoid receptor regulatory network—TP53—muscle cancer	0.000303	0.00383	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—FOXO1—muscle cancer	0.000301	0.00381	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.000299	0.00377	CbGpPWpGaD
Aminophylline—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000294	0.00198	CcSEcCtD
Aminophylline—Pruritus—Methotrexate—muscle cancer	0.000294	0.00197	CcSEcCtD
Aminophylline—Urticaria—Doxorubicin—muscle cancer	0.000286	0.00192	CcSEcCtD
Aminophylline—Abdominal pain—Doxorubicin—muscle cancer	0.000284	0.00191	CcSEcCtD
Aminophylline—Body temperature increased—Doxorubicin—muscle cancer	0.000284	0.00191	CcSEcCtD
Aminophylline—Diarrhoea—Methotrexate—muscle cancer	0.000284	0.00191	CcSEcCtD
Aminophylline—ADORA2A—GPCR ligand binding—CNR1—muscle cancer	0.000284	0.00358	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—IGF2—muscle cancer	0.000279	0.00353	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KIDINS220—muscle cancer	0.000279	0.00352	CbGpPWpGaD
Aminophylline—Dizziness—Methotrexate—muscle cancer	0.000275	0.00184	CcSEcCtD
Aminophylline—Hypersensitivity—Doxorubicin—muscle cancer	0.000265	0.00178	CcSEcCtD
Aminophylline—Vomiting—Methotrexate—muscle cancer	0.000264	0.00177	CcSEcCtD
Aminophylline—ADORA2B—Signaling by GPCR—PTCH1—muscle cancer	0.000263	0.00332	CbGpPWpGaD
Aminophylline—Rash—Methotrexate—muscle cancer	0.000262	0.00176	CcSEcCtD
Aminophylline—Dermatitis—Methotrexate—muscle cancer	0.000262	0.00176	CcSEcCtD
Aminophylline—Headache—Methotrexate—muscle cancer	0.00026	0.00175	CcSEcCtD
Aminophylline—ADORA2A—Signaling Pathways—KIDINS220—muscle cancer	0.000259	0.00327	CbGpPWpGaD
Aminophylline—HDAC2—Cell Cycle—TP53—muscle cancer	0.000255	0.00322	CbGpPWpGaD
Aminophylline—Pruritus—Doxorubicin—muscle cancer	0.000255	0.00171	CcSEcCtD
Aminophylline—HDAC2—Signaling by NGF—KIT—muscle cancer	0.000247	0.00312	CbGpPWpGaD
Aminophylline—Nausea—Methotrexate—muscle cancer	0.000247	0.00166	CcSEcCtD
Aminophylline—Diarrhoea—Doxorubicin—muscle cancer	0.000246	0.00165	CcSEcCtD
Aminophylline—ADORA2B—GPCR downstream signaling—CNR1—muscle cancer	0.000244	0.00309	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NOTCH—TP53—muscle cancer	0.000241	0.00305	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—PTCH1—muscle cancer	0.000239	0.00301	CbGpPWpGaD
Aminophylline—Dizziness—Doxorubicin—muscle cancer	0.000238	0.0016	CcSEcCtD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000235	0.00297	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—PTCH1—muscle cancer	0.000232	0.00293	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—KIT—muscle cancer	0.00023	0.0029	CbGpPWpGaD
Aminophylline—Vomiting—Doxorubicin—muscle cancer	0.000229	0.00154	CcSEcCtD
Aminophylline—Rash—Doxorubicin—muscle cancer	0.000227	0.00152	CcSEcCtD
Aminophylline—Dermatitis—Doxorubicin—muscle cancer	0.000227	0.00152	CcSEcCtD
Aminophylline—Headache—Doxorubicin—muscle cancer	0.000225	0.00151	CcSEcCtD
Aminophylline—ADORA1—Signaling by GPCR—PTCH1—muscle cancer	0.000223	0.00282	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—IGF2—muscle cancer	0.000223	0.00282	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—CNR1—muscle cancer	0.000222	0.0028	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—CNR1—muscle cancer	0.000222	0.0028	CbGpPWpGaD
Aminophylline—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	0.000217	0.00274	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—CNR1—muscle cancer	0.000216	0.00273	CbGpPWpGaD
Aminophylline—Nausea—Doxorubicin—muscle cancer	0.000214	0.00143	CcSEcCtD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	0.000209	0.00264	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—CNR1—muscle cancer	0.000208	0.00262	CbGpPWpGaD
Aminophylline—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—muscle cancer	0.000202	0.00256	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—CNR1—muscle cancer	0.000201	0.00254	CbGpPWpGaD
Aminophylline—HDAC2—Direct p53 effectors—TP53—muscle cancer	0.000198	0.0025	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—CNR1—muscle cancer	0.000196	0.00248	CbGpPWpGaD
Aminophylline—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000195	0.00247	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—MED12—muscle cancer	0.000195	0.00246	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—MDM2—muscle cancer	0.000195	0.00246	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—CNR1—muscle cancer	0.000189	0.00238	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—MDM2—muscle cancer	0.000181	0.00228	CbGpPWpGaD
Aminophylline—ADORA1—Circadian rythm related genes—TP53—muscle cancer	0.000178	0.00225	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—PTCH1—muscle cancer	0.000173	0.00218	CbGpPWpGaD
Aminophylline—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	0.000167	0.00211	CbGpPWpGaD
Aminophylline—HDAC2—Disease—ENO2—muscle cancer	0.000165	0.00209	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	0.000164	0.00208	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—CNR1—muscle cancer	0.00016	0.00203	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—PTCH1—muscle cancer	0.000155	0.00196	CbGpPWpGaD
Aminophylline—HDAC2—Disease—HMGA1—muscle cancer	0.00015	0.0019	CbGpPWpGaD
Aminophylline—HDAC2—Circadian rythm related genes—TP53—muscle cancer	0.000148	0.00187	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—CNR1—muscle cancer	0.000146	0.00184	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PTCH1—muscle cancer	0.000141	0.00178	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—TP53—muscle cancer	0.000138	0.00174	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PTCH1—muscle cancer	0.000137	0.00173	CbGpPWpGaD
Aminophylline—HDAC2—Disease—FOXO4—muscle cancer	0.000135	0.0017	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—FOXO4—muscle cancer	0.000134	0.00169	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PTCH1—muscle cancer	0.000132	0.00167	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CNR1—muscle cancer	0.000131	0.00166	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—FOXO4—muscle cancer	0.000121	0.00153	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CNR1—muscle cancer	0.000119	0.0015	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—FOXO4—muscle cancer	0.000118	0.00149	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—VEGFA—muscle cancer	0.000117	0.00148	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CNR1—muscle cancer	0.000116	0.00146	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—FH—muscle cancer	0.000115	0.00146	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—FOXO4—muscle cancer	0.000114	0.00143	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CNR1—muscle cancer	0.000111	0.00141	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PTCH1—muscle cancer	0.00011	0.00138	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—IGF2—muscle cancer	0.000107	0.00135	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PTCH1—muscle cancer	0.000102	0.00129	CbGpPWpGaD
Aminophylline—HDAC2—Disease—FOXO1—muscle cancer	9.94e-05	0.00126	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—FOXO1—muscle cancer	9.86e-05	0.00125	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—IGF2—muscle cancer	9.73e-05	0.00123	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—IGF2—muscle cancer	9.46e-05	0.0012	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—FOXO4—muscle cancer	9.43e-05	0.00119	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—VEGFA—muscle cancer	9.36e-05	0.00118	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CNR1—muscle cancer	9.25e-05	0.00117	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IGF2—muscle cancer	9.11e-05	0.00115	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—FOXO1—muscle cancer	8.95e-05	0.00113	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—TP53—muscle cancer	8.85e-05	0.00112	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	8.79e-05	0.00111	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—FOXO4—muscle cancer	8.76e-05	0.00111	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—FOXO1—muscle cancer	8.71e-05	0.0011	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CNR1—muscle cancer	8.6e-05	0.00109	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—FOXO1—muscle cancer	8.38e-05	0.00106	CbGpPWpGaD
Aminophylline—HDAC2—Disease—KIT—muscle cancer	7.58e-05	0.000957	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IGF2—muscle cancer	7.57e-05	0.000956	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—KIT—muscle cancer	7.51e-05	0.000949	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—TP53—muscle cancer	7.07e-05	0.000893	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IGF2—muscle cancer	7.03e-05	0.000888	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—FOXO1—muscle cancer	6.96e-05	0.000879	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—FH—muscle cancer	6.93e-05	0.000875	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—KIT—muscle cancer	6.82e-05	0.000862	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—KIT—muscle cancer	6.64e-05	0.000838	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—MED12—muscle cancer	6.51e-05	0.000822	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—FOXO1—muscle cancer	6.47e-05	0.000818	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—KIT—muscle cancer	6.39e-05	0.000807	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MDM2—muscle cancer	5.97e-05	0.000754	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ENO2—muscle cancer	5.94e-05	0.00075	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MDM2—muscle cancer	5.92e-05	0.000747	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PTGS2—muscle cancer	5.75e-05	0.000727	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MDM2—muscle cancer	5.37e-05	0.000679	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—FH—muscle cancer	5.35e-05	0.000675	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KIT—muscle cancer	5.31e-05	0.00067	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MDM2—muscle cancer	5.23e-05	0.00066	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MDM2—muscle cancer	5.03e-05	0.000635	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KIT—muscle cancer	4.93e-05	0.000623	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—VEGFA—muscle cancer	4.49e-05	0.000568	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MDM2—muscle cancer	4.18e-05	0.000528	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—VEGFA—muscle cancer	4.08e-05	0.000515	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—VEGFA—muscle cancer	3.97e-05	0.000501	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—MED12—muscle cancer	3.91e-05	0.000494	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MDM2—muscle cancer	3.88e-05	0.000491	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—VEGFA—muscle cancer	3.82e-05	0.000483	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ENO2—muscle cancer	3.57e-05	0.000451	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TP53—muscle cancer	3.4e-05	0.000429	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—VEGFA—muscle cancer	3.17e-05	0.000401	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TP53—muscle cancer	3.08e-05	0.000389	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—MED12—muscle cancer	3.02e-05	0.000382	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TP53—muscle cancer	3e-05	0.000379	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—VEGFA—muscle cancer	2.95e-05	0.000373	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TP53—muscle cancer	2.89e-05	0.000365	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.79e-05	0.000353	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ENO2—muscle cancer	2.75e-05	0.000348	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TP53—muscle cancer	2.4e-05	0.000303	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TP53—muscle cancer	2.23e-05	0.000282	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTGS2—muscle cancer	2.07e-05	0.000261	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTGS2—muscle cancer	1.24e-05	0.000157	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTGS2—muscle cancer	9.59e-06	0.000121	CbGpPWpGaD
